Table: begin end state 1 28 signal peptide 29 40 non-cytoplasmic 41 64 transmembrane 65 81 cytoplasmic 82 103 transmembrane 104 147 non-cytoplasmic 148 169 transmembrane 170 196 cytoplasmic 197 218 transmembrane 219 223 non-cytoplasmic 224 250 transmembrane 251 261 cytoplasmic 262 283 transmembrane 284 312 non-cytoplasmic 313 330 transmembrane 331 336 cytoplasmic 337 354 transmembrane 355 359 non-cytoplasmic 360 382 transmembrane 383 422 cytoplasmic
Input: >WP_200770547.1 NCBI__GCF_900141795.1:WP_200770547.1 MKLALHWQILLALALAVLMGWLTGTDATILGVHWIAIYDFIGTLFLNALKMVVVPLVMAA IITGMASIARQGGFGRLGLKTLGYYLMTSAIAILIGITLVNLIQPGVSDNPPPQIAADTQ LQQKLEGRDIGDIAEVFLRMIPTNIVEAAAETQMLGLIFFSLLFGYFMMKIQTPYRDTLY NFWQGVFEVMMQITEWVMKFAPLGVFGLVAASVARTGFDQFANLALFFITVVLALGIHFF VVMPLILRFIGGVRNPWKHYKVMLPAILTAFSTSSSASTLPVTIECVERGAGVPNRISGF VLPLGATVNMDGTALYEAVAALFIAQLFGVHLDVTQQFMIIVIALLTSIGVAGIPSASLV AISIILVSVGLPAEAIGLLLVVDRLLDMMRTTVNIFSDSVGAVVIARSEGEKDVLEGDGR CG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server